Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech

Wed, 02/06/2019 - 6:21am

Genentech will pay $120m up front to co-develop Xencor’s preclinical IL-15 candidate; deal also includes IL-15 R&D. Taiho licenses lung...

      Related Stories 

How Novartis Is Making SENSE Of Clinical Data In Digital Age

Wed, 02/06/2019 - 6:09am

The Swiss major has been showcasing its Nerve Live data analytics platform, where staff stationed at its SENSE operations center...

      Related Stories 

Sanofi Poised To File Isatuximab In Multiple Myeloma, Going Up Against J&J's Darzalex

Tue, 02/05/2019 - 11:26am

Isatuximab could be the next building block in Sanofi's ambitions to rebuild in oncology. The CD38-targeting antibody extended PFS in...

      Related Stories 

GSK Makes I-O Move With Merck KGaA Deal Worth Up To €3.7bn

Tue, 02/05/2019 - 6:03am

Already working with Pfizer on the immunotherapy Bavencio, Merck KGaA has bagged another big pharma player in GSK to progress...

      Related Stories 

Merck KGaA's Exploring Of DNA-PK In Cancer ‘Unchanged’ By Vertex Gene-Editing Deal

Tue, 02/05/2019 - 2:30am

Merck KGaA says a gene-editing deal last month with Vertex Pharma involving DNA-dependent protein kinase inhibitors will not alter its plans...

      Related Stories 

Another Infliximab Biosimilar On Horizon In India?

Mon, 02/04/2019 - 11:46pm

More competition appears to be in the wings for Remicade in India after the Russian firm Biocad’s biosimilar infliximab was...

      Related Stories 

Simbec-Orion MBO Underpins Build And Buy Strategy

Mon, 02/04/2019 - 9:48pm

Private equity group CBPE Capital acquires majority stake in UK CRO and will finance expansion into US; deal provides Welsh...

      Related Stories 

Medicxi Links With Sosei Heptares For Orexin Agonist Vehicles

Mon, 02/04/2019 - 9:32pm

After spending 12 months looking for promising orexin agonist candidates, asset-centric venture capitalist Medicxi finds answer close to home and...

      Related Stories 

DATA: Start-Up Quarterly Statistics: Relay, Cerevel Financings Lead Q4 VC Deals

Mon, 02/04/2019 - 4:50pm

A review of biopharma start-up dealmaking and financing activity from October through December 2018, based on data from Strategic Transactions.

      Related Stories 

Gilead Maintains Optimistic Outlook For Yescarta Despite Slow Growth

Mon, 02/04/2019 - 2:24pm

Gilead projects roughly $200m in sales growth for its CAR-T product Yescarta, despite the drug’s modest $6m sequential growth during...

      Related Stories 

Q4 Pharma Earnings Preview: GSK, Lilly, Sanofi And AstraZeneca

Mon, 02/04/2019 - 12:02pm

GlaxoSmithKline will update investors on strategy after completing its Tesaro acquisition. Lilly may have guidance updates following its Loxo acquisition...

      Related Stories 

Pipeline Watch: Top-Line Phase III Results For Tanezumab, Dengue Vaccine, Ibrexafungerp

Mon, 02/04/2019 - 12:32am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories